Citations (140)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Abdelrady Shehata Ibrahim, Waleed Saleh Farrag & Mohamed Galal Aly. (2018) Ultrasound guided bilateral rectus sheath block and serum TNF-α and IL-6 after radical prostatectomy: A randomized double blinded study. Egyptian Journal of Anaesthesia 34:4, pages 139-143.
Read now
Read now
Pauline Vandame, Corentin Spriet, Dave Trinel, Armance Gelaude, Katia Caillau, Coralie Bompard, Emanuele Biondi & Jean-François Bodart. (2014) The spatio-temporal dynamics of PKA activity profile during mitosis and its correlation to chromosome segregation. Cell Cycle 13:20, pages 3232-3240.
Read now
Read now
Alfredo Berruti, Francesca Vignani, Lucianna Russo, Valentina Bertaglia, Mattia Tullio, Marcello Tucci, Massimiliano Poggio & Luigi Dogliotti. (2010) Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. Open Access Journal of Urology 2, pages 109-124.
Read now
Read now
Zoran Culig. (2006) Endocrine regulation of prostate cancer growth. Expert Review of Endocrinology & Metabolism 1:3, pages 379-389.
Read now
Read now
Articles from other publishers (136)
Lina Merkens, Verena Sailer, Davor Lessel, Ella Janzen, Sarah Greimeier, Jutta Kirfel, Sven Perner, Klaus Pantel, Stefan Werner & Gunhild von Amsberg. (2022) Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Ida Deichaite, Timothy J. Sears, Leisa Sutton, Daniel Rebibo, Kylie Morgan, Tyler Nelson, Brent Rose, Pablo Tamayo, Napoleone Ferrara, Fotis Asimakopoulos & Hannah Carter. (2022) Differential regulation of TNFα and IL-6 expression contributes to immune evasion in prostate cancer. Journal of Translational Medicine 20:1.
Crossref
Crossref
Ahmed A. H. Abdellatif, Ahmed Abdelfattah, Abdellatif Bouazzaoui, Shaaban K. Osman, Issa Saad Al-Moraya, Abdulaziz M. Saleh Showail, Mansour Alsharidah, Ashraf Aboelela, Osamah Al Rugaie, Tarek M. Faris & Hesham M. Tawfeek. (2022) Silver Nanoparticles Stabilized by Poly (Vinyl Pyrrolidone) with Potential Anticancer Activity towards Prostate Cancer. Bioinorganic Chemistry and Applications 2022, pages 1-12.
Crossref
Crossref
Lin Gao, Bo Han & Xuesen Dong. (2022) The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression. Frontiers in Oncology 12.
Crossref
Crossref
Pablo Sanchis, Nicolas Anselmino, Sofia Lage-Vickers, Agustina Sabater, Rosario Lavignolle, Estefania Labanca, Peter D. A. Shepherd, Juan Bizzotto, Ayelen Toro, Antonina Mitrofanova, Maria Pia Valacco, Nora Navone, Elba Vazquez, Javier Cotignola & Geraldine Gueron. (2022) Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells. Cancers 14:9, pages 2083.
Crossref
Crossref
Xue Shui, Rong Xu, Caiqin Zhang, Han Meng, Jumei Zhao & Changhong Shi. (2022) Advances in neuroendocrine prostate cancer research: From model construction to molecular network analyses. Laboratory Investigation 102:4, pages 332-340.
Crossref
Crossref
Jake L. Owens, Elena Beketova, Sheng Liu, Qi Shen, Jogendra Singh Pawar, Andrew M. Asberry, Jie Yang, Xuehong Deng, Bennett D. Elzey, Timothy L. Ratliff, Liang Cheng, Richard Choo, Deborah E. Citrin, Thomas J. Polascik, Bangchen Wang, Jiaoti Huang, Chenglong Li, Jun Wan & Chang-Deng Hu. (2022) Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation. Molecular Cancer Therapeutics 21:3, pages 448-459.
Crossref
Crossref
Sirisha Natani, K.K. Sruthi, Sakkarai Mohamed Asha, Priyanka Khilar, Pampana Sandhya Venkata Lakshmi & Ramesh Ummanni. (2022) Activation of TGF-β - SMAD2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK. Cellular Signalling 91, pages 110240.
Crossref
Crossref
Sirisha Natani, Vishnu M. Dhople, Asha Parveen, K.K. Sruthi, Priyanka Khilar, Supriya Bhukya & Ramesh Ummanni. (2021) AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1868:10, pages 119085.
Crossref
Crossref
Dali Tong. (2021) Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype. Critical Reviews in Oncology/Hematology 163, pages 103370.
Crossref
Crossref
William Butler & Jiaoti Huang. (2021) Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms. Precision Clinical Medicine 4:1, pages 25-34.
Crossref
Crossref
Sudhir Kumar, Jyoti Kashyap, Keshav Thakur & Rakesh K. Tyagi. 2021. Nuclear Receptors. Nuclear Receptors
23
36
.
Hongying Zhang, Qingbin Kong, Jiao Wang, Yangfu Jiang & Hui Hua. (2020) Complex roles of cAMP–PKA–CREB signaling in cancer. Experimental Hematology & Oncology 9:1.
Crossref
Crossref
Abrar Samiea, Jeff S. J. Yoon, Christopher J. Ong, Amina Zoubeidi, Thomas C. Chamberlain & Alice L.-F. Mui. (2020) Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells. Prostate Cancer 2020, pages 1-12.
Crossref
Crossref
Zheng Wang, Yicheng Zhao, Zhiqiang An & Wenliang Li. (2020) Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression. Frontiers in Oncology 9.
Crossref
Crossref
Anita Hryniewicz-Jankowska, Katarzyna Augoff & Aleksander F Sikorski. (2019) The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer. Experimental Biology and Medicine 244:13, pages 1053-1061.
Crossref
Crossref
Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, Lawrence D. True, Lori Kollath, Bryce Lakely, Holly M. Nguyen, Yu C. Yang, Rui M. Gil da Costa, Arja Kaipainen, Roger Coleman, Celestia S. Higano, Evan Y. Yu, Heather H. Cheng, Elahe A. Mostaghel, Bruce Montgomery, Michael T. Schweizer, Andrew C. Hsieh, Daniel W. Lin, Eva Corey, Peter S. Nelson & Colm Morrissey. (2019) Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. Journal of Clinical Investigation 129:10, pages 4492-4505.
Crossref
Crossref
Yinan Li, Ning Xie, Ruiqi Chen, Ahn R. Lee, Jessica Lovnicki, Emma A. Morrison, Ladan Fazli, Qingfu Zhang, Catherine A. Musselman, Yuzhuo Wang, Jiaoti Huang, Martin E. Gleave, Colin Collins & Xuesen Dong. (2019) RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression. European Urology 76:2, pages 157-166.
Crossref
Crossref
Yunshin Yeh, Qiaozhi Guo, Zachary Connelly, Siyuan Cheng, Shu Yang, Nestor Prieto-Dominguez & Xiuping Yu. 2019. Prostate Cancer. Prostate Cancer
351
378
.
Rongying Zhu, Xiaodong Yang, Xiang Xue, Mingjing Shen, Feng Chen, Xiaodong Chen, Ying Tsai, Peter C. Keng, Yongbing Chen, Soo Ok Lee & Yuhchyau Chen. (2018) RETRACTED: Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1865:12, pages 1878-1890.
Crossref
Crossref
Jaroslaw Thomas Dankert, Marc Wiesehöfer, Elena Dilara Czyrnik, Bernhard B. Singer, Nicola von Ostau & Gunther Wennemuth. (2018) The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells. PLOS ONE 13:7, pages e0200472.
Crossref
Crossref
Irasema Mendieta, Rosa Elvira Nuñez-Anita, Gilberto Pérez-Sánchez, Lenin Pavón, Alfredo Rodríguez-Cruz, Guadalupe García-Alcocer & Laura Cristina Berumen. (2018) Effect of A549 neuroendocrine differentiation on cytotoxic immune response. Endocrine Connections 7:5, pages 791-802.
Crossref
Crossref
Robert K. Nam, Tania Benatar, Yutaka Amemiya, Christopher J.D. Wallis, Joan Miguel Romero, Melina Tsagaris, Christopher Sherman, Linda Sugar & Arun Seth. (2018) MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells. Oncotarget 9:27, pages 19159-19176.
Crossref
Crossref
Shusuke Akamatsu, Takahiro Inoue, Osamu Ogawa & Martin E Gleave. (2018) Clinical and molecular features of treatment-related neuroendocrine prostate cancer. International Journal of Urology 25:4, pages 345-351.
Crossref
Crossref
Zoran Culig & Martin Puhr. (2018) Interleukin-6 and prostate cancer: Current developments and unsolved questions. Molecular and Cellular Endocrinology 462, pages 25-30.
Crossref
Crossref
Oded Danziger, Tal Pupko, Eran Bacharach & Marcelo Ehrlich. (2018) Interleukin-6 and Interferon-α Signaling via JAK1–STAT Differentially Regulate Oncolytic versus Cytoprotective Antiviral States. Frontiers in Immunology 9.
Crossref
Crossref
Shusuke Akamatsu. 2018. Hormone Therapy and Castration Resistance of Prostate Cancer. Hormone Therapy and Castration Resistance of Prostate Cancer
387
396
.
Ashutosh K. Tewari, Jennifer A. Stockert, Shalini S. Yadav, Kamlesh K. Yadav & Irtaza Khan. 2018. Cell & Molecular Biology of Prostate Cancer. Cell & Molecular Biology of Prostate Cancer
41
65
.
Yinan Li, Ruiqi Chen, Mary Bowden, Fan Mo, Yen-Yi Lin, Martin Gleave, Colin Collins & Xuesen Dong. (2017) Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4. Oncotarget 8:40, pages 66878-66888.
Crossref
Crossref
Andrew Farach, Yi Ding, MinJae Lee, Chad Creighton, Nikki A. Delk, Michael Ittmann, Brian Miles, David Rowley, Mary C. Farach-Carson & Gustavo E. Ayala. (2016) Neuronal Trans-Differentiation in Prostate Cancer Cells. The Prostate 76:14, pages 1312-1325.
Crossref
Crossref
Cecilia Morell, Alicia Bort, Diana Vara-Ciruelos, Ágata Ramos-Torres, Manuel Altamirano-Dimas, Inés Díaz-Laviada & Nieves Rodríguez-Henche. (2016) Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells. PLOS ONE 11:9, pages e0162977.
Crossref
Crossref
Tom Moritz, Simone Venz, Heike Junker, Sarah Kreuz, Reinhard Walther & Uwe Zimmermann. (2016) Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells. Tumor Biology 37:8, pages 10435-10446.
Crossref
Crossref
Meixiang Sang, Mohit Hulsurkar, Xiaochong Zhang, Haiping Song, Dayong Zheng, Yan Zhang, Min Li, Jianming Xu, Songlin Zhang, Michael Ittmann & Wenliang Li. (2016) GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells. Oncotarget 7:29, pages 45171-45185.
Crossref
Crossref
Tzu-Ping Lin, Yi-Ting Chang, Sung-Yuan Lee, Mel Campbell, Tien-Chiao Wang, Shu-Huei Shen, Hsiao-Jen Chung, Yen-Hwa Chang, Allen W. Chiu, Chin-Chen Pan, Chi-Hung Lin, Cheng-Ying Chu, Hsing-Jien Kung, Chia-Yang Cheng & Pei-Ching Chang. (2016) REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling. Oncotarget 7:18, pages 26137-26151.
Crossref
Crossref
XUECHAO LI, TAO LI, DEHONG CHEN, PENG ZHANG, YARONG SONG, HONGXUE ZHU, YAJUN XIAO & YIFEI XING. (2016) Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway. Oncology Reports 35:1, pages 584-592.
Crossref
Crossref
Evangelina Delgado-González, Ana Alicia Sánchez-Tusie, Giapsy Morales, Carmen Aceves & Brenda Anguiano. (2016) Triiodothyronine Attenuates Prostate Cancer Progression Mediated by β-Adrenergic Stimulation. Molecular Medicine 22:1, pages 1-11.
Crossref
Crossref
Sivanandane Sittadjody, Thilakavathy Thangasamy, Bita NickKolgh & K. C. Balaji. 2016. Managing Metastatic Prostate Cancer In Your Urological Oncology Practice. Managing Metastatic Prostate Cancer In Your Urological Oncology Practice
35
63
.
Erika M. Weaver, Francis J. Zamora, Jennifer L. Hearne & Miguel Martin-Caraballo. (2015) Posttranscriptional regulation of T-type Ca2+ channel expression by interleukin-6 in prostate cancer cells. Cytokine 76:2, pages 309-320.
Crossref
Crossref
Masatoshi Ohnishi, Tomoka Urasaki, Hiroyuki Ochiai, Kohei Matsuoka, Shin Takeo, Tomoki Harada, Yoshihito Ohsugi & Atsuko Inoue. (2015) Selective enhancement of wnt4 expression by cyclic AMP-associated cooperation between rat central astrocytes and microglia. Biochemical and Biophysical Research Communications 467:2, pages 367-372.
Crossref
Crossref
Kazuki Fukami, Fumiko Sekiguchi, Miku Yasukawa, Erina Asano, Ryuji Kasamatsu, Mai Ueda, Shigeru Yoshida & Atsufumi Kawabata. (2015) Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells. Biochemical Pharmacology 97:3, pages 300-309.
Crossref
Crossref
Peder Rustøen Braadland, Håkon Ramberg, Helene Hartvedt Grytli & Kristin Austlid Taskén. (2015) β-Adrenergic Receptor Signaling in Prostate Cancer. Frontiers in Oncology 4.
Crossref
Crossref
Rakesh K. Mishra & Ashutosh K. Tewari. (2015) Erratum to “Inflammation and Its Role in Prostate Cancer” [Journal of Cancer Therapy 5 (2014) 836-844]. Journal of Cancer Therapy 06:01, pages 109-113.
Crossref
Crossref
Marine Warnier, Florian Gackière, Morad Roudbaraki & Pascal Mariot. 2015. T-type Calcium Channels in Basic and Clinical Science. T-type Calcium Channels in Basic and Clinical Science
51
71
.
Zuzana Pernicová, Eva Slabáková, Radek Fedr, Šárka Šimečková, Josef Jaroš, Tereza Suchánková, Jan Bouchal, Gvantsa Kharaishvili, Milan Král, Alois Kozubík & Karel Souček. (2014) The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells. Molecular Cancer 13:1.
Crossref
Crossref
L Gangoda, M Doerflinger, R Srivastava, N Narayan, L E Edgington, J Orian, C Hawkins, L A O'Reilly, H Gu, M Bogyo, P Ekert, A Strasser & H Puthalakath. (2014) Loss of Prkar1a leads to Bcl-2 family protein induction and cachexia in mice. Cell Death & Differentiation 21:11, pages 1815-1824.
Crossref
Crossref
Yezi Zhu, Chengfei Liu, Yuanyuan Cui, Nagalakshmi Nadiminty, Wei Lou & Allen C. Gao. (2014) Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST). The Prostate 74:11, pages 1086-1094.
Crossref
Crossref
Verity G. Kew, Jinxiang Yuan, Jeffery Meier & Matthew B. Reeves. (2014) Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency. PLoS Pathogens 10:6, pages e1004195.
Crossref
Crossref
Daniel P. Nguyen, Jinyi Li & Ashutosh K. Tewari. (2014) Inflammation and prostate cancer: the role of interleukin 6 (IL-6). BJU International 113:6, pages 986-992.
Crossref
Crossref
Lei Gu, Pooja Talati, Paraskevi Vogiatzi, Ana L. Romero-Weaver, Junaid Abdulghani, Zhiyong Liao, Benjamin Leiby, David T. Hoang, Tuomas Mirtti, Kalle Alanen, Michael Zinda, Dennis Huszar & Marja T. Nevalainen. (2014) Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6–Induced Experimental Prostate Cancer Metastases Formation. Molecular Cancer Therapeutics 13:5, pages 1246-1258.
Crossref
Crossref
Pei-Ching Chang, Tao-Yeuan Wang, Yi-Ting Chang, Cheng-Ying Chu, Chin-Ling Lee, Hung-Wei Hsu, Tyng-An Zhou, Zhaoju Wu, Randie H. Kim, Sonal J. Desai, Shangqin Liu & Hsing-Jien Kung. (2014) Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells. PLoS ONE 9:2, pages e88556.
Crossref
Crossref
Rakesh K. Mishra & Ashutosh K. Tewari. (2014) Inflammation and Its Role in Prostate Cancer. Journal of Cancer Therapy 05:09, pages 836-844.
Crossref
Crossref
Himisha Beltran, Gurveen Kaur, Myriam Kossai, David M. Nanus & Scott T. Tagawa. 2014. Management of Castration Resistant Prostate Cancer. Management of Castration Resistant Prostate Cancer
297
304
.
Yang Zong, Andrew S. Goldstein & JiaoTi Huang. (2013) The molecular basis for ethnic variation and histological subtype differences in prostate cancer. Science China Life Sciences 56:9, pages 780-787.
Crossref
Crossref
Ida Rapa, Marco Volante, Cristina Migliore, Antonella Farsetti, Alfredo Berruti, Giorgio Vittorio Scagliotti, Silvia Giordano & Mauro Papotti. (2013) Human ASH-1 Promotes Neuroendocrine Differentiation in Androgen Deprivation Conditions and Interferes With Androgen Responsiveness in Prostate Cancer Cells. The Prostate 73:11, pages 1241-1249.
Crossref
Crossref
Jessy Alonzeau, David Alexandre, Lydie Jeandel, Maïté Courel, Coralie Hautot, Fatima-Zohra El Yamani, Françoise Gobet, Jérôme Leprince, Rabia Magoul, Afaf Amarti, Christian Pfister, Laurent Yon, Youssef Anouar & Nicolas Chartrel. (2013) The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells. European Journal of Cancer 49:2, pages 511-519.
Crossref
Crossref
Renato Franco, Paolo Chieffi, Sisto Perdonà, Gaetano Facchini & Michele Caraglia. 2013. Prostate Cancer: Shifting from Morphology to Biology. Prostate Cancer: Shifting from Morphology to Biology
87
109
.
Francois Lamoureux, Amina Zoubeidi & Martin E. Gleave. 2013. Prostate Cancer: A Comprehensive Perspective. Prostate Cancer: A Comprehensive Perspective
43
64
.
Dongxia Ge, Allen C. Gao, Qiuyang Zhang, Sen Liu, Yun Xue & Zongbing You. (2012) LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling. The Prostate 72:12, pages 1306-1316.
Crossref
Crossref
Sarah E. Jones & Timothy M. Palmer. (2012) Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells. Cellular Signalling 24:8, pages 1504-1514.
Crossref
Crossref
Latif A. Wafa, Helen Cheng, Nathan Plaa, Fariba Ghaidi, Takahiro Fukumoto, Ladan Fazli, Martin E. Gleave, Michael E. Cox & Paul S. Rennie. (2012) Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression. International Journal of Cancer 130:12, pages 2835-2844.
Crossref
Crossref
Yezi Zhu, Ramakumar Tummala, Chengfei Liu, Nagalakshmi Nadiminty, Wei Lou, Christopher P. Evans, Qinghua Zhou & Allen C. Gao. (2012) RhoGDIα suppresses growth and survival of prostate cancer cells. The Prostate 72:4, pages 392-398.
Crossref
Crossref
Valérie Perrot. (2012) Neuroendocrine Differentiation in the Progression of Prostate Cancer: An Update on Recent Developments. Open Journal of Urology 02:03, pages 173-182.
Crossref
Crossref
Levent Sagnak, Hikmet Topaloglu, Ugur Ozok & Hamit Ersoy. (2011) Prognostic Significance of Neuroendocrine Differentiation in Prostate Adenocarcinoma. Clinical Genitourinary Cancer 9:2, pages 73-80.
Crossref
Crossref
Iori Sakai, Hideaki Miyake, Tomoaki Terakawa & Masato Fujisawa. (2011) Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model. Cancer Science 102:4, pages 769-775.
Crossref
Crossref
Dennis Merkle & Ralf Hoffmann. (2011) Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: Cross-talk with the androgen receptor. Cellular Signalling 23:3, pages 507-515.
Crossref
Crossref
Isabel Quiros-Gonzalez, Rosa M. Sainz, David Hevia & Juan C. Mayo. (2011) MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells. Free Radical Biology and Medicine 50:4, pages 525-536.
Crossref
Crossref
Jianfei Qi, Maurizio Pellecchia & Ze’ev A. Ronai. (2010) The Siah2-HIF-FoxA2 axis in prostate cancer - new markers and therapeutic opportunities. Oncotarget 1:5, pages 379-385.
Crossref
Crossref
Jianfei Qi, Koh Nakayama, Robert D. Cardiff, Alexander D. Borowsky, Karen Kaul, Roy Williams, Stan Krajewski, Dan Mercola, Philip M. Carpenter, David Bowtell & Ze'ev A. Ronai. (2010) Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors. Cancer Cell 18:1, pages 23-38.
Crossref
Crossref
J Wang, J Kim, M Roh, O E Franco, S W Hayward, M L Wills & S A Abdulkadir. (2010) Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Oncogene 29:17, pages 2477-2487.
Crossref
Crossref
Houjin Huang, Erik Pierstorff, Karen Liu, Eiji Ōsawa & Dean Ho. 2010. Nanodiamonds. Nanodiamonds
151
174
.
Smitha S Dutt & Allen C Gao. (2009) Molecular mechanisms of castration-resistant prostate cancer progression. Future Oncology 5:9, pages 1403-1413.
Crossref
Crossref
T Terakawa, H Miyake, J Furukawa, S L Ettinger, M E Gleave & M Fujisawa. (2009) Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells. British Journal of Cancer 101:10, pages 1731-1739.
Crossref
Crossref
John DaSilva, Daniel Gioeli, Michael J. Weber & Sarah J. Parsons. (2009) The Neuroendocrine-Derived Peptide Parathyroid Hormone–Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor. Cancer Research 69:18, pages 7402-7411.
Crossref
Crossref
Jae Yeon Chun, Nagalakshmi Nadiminty, Smitha Dutt, Wei Lou, Joy C. Yang, Hsing-Jien Kung, Christopher P. Evans & Allen C. Gao. (2009) Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells. Clinical Cancer Research 15:15, pages 4815-4822.
Crossref
Crossref
Akira Komiya, Hiroyoshi Suzuki, Takashi Imamoto, Naoto Kamiya, Naoki Nihei, Yukio Naya, Tomohiko Ichikawa & Hideki Fuse. (2009) Neuroendocrine differentiation in the progression of prostate cancer. International Journal of Urology 16:1, pages 37-44.
Crossref
Crossref
Hsing-Jien Kung & Christopher P. Evans. (2009) Oncogenic activation of androgen receptor. Urologic Oncology: Seminars and Original Investigations 27:1, pages 48-52.
Crossref
Crossref
Ryutaro Mori, Shigang Xiong, Qingcai Wang, Chad Tarabolous, Hiroshi Shimada, Eleftherios Panteris, Kathleen D. Danenberg, Peter V. Danenberg & Jacek K. Pinski. (2009) Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells. The Prostate 69:1, pages 12-23.
Crossref
Crossref
Sangmin Kim, Yoonkyung Kim, Ji Eun Kim, Kwang Hyun Cho & Jin Ho Chung. (2008) Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes. Phytomedicine 15:5, pages 340-347.
Crossref
Crossref
Jodie Palmer, Vasundara Venkateswaran, Neil E. Fleshner, Laurence H. Klotz & Michael E. Cox. (2008) The impact of diet and micronutrient supplements on the expression of neuroendocrine markers in murineLady transgenic prostate. The Prostate 68:4, pages 345-353.
Crossref
Crossref
Houjin Huang, Erik Pierstorff, Eiji Osawa & Dean Ho. (2008) Protein-Mediated Assembly of Nanodiamond Hydrogels into a Biocompatible and Biofunctional Multilayer Nanofilm. ACS Nano 2:2, pages 203-212.
Crossref
Crossref
C Berenguer, F Boudouresque, C Dussert, L Daniel, X Muracciole, M Grino, D Rossi, K Mabrouk, D Figarella-Branger, P-M Martin & L'Houcine Ouafik. (2007) Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates ‘neuroendocrine phenotype’ in LNCaP prostate tumor cells. Oncogene 27:4, pages 506-518.
Crossref
Crossref
Zoran Culig, Richard G. Pestell & Marja T. Nevalainen. 2008. Prostate Cancer. Prostate Cancer
257
290
.
Houjin Huang, Erik Pierstorff, Eiji Osawa & Dean Ho. (2007) Active Nanodiamond Hydrogels for Chemotherapeutic Delivery. Nano Letters 7:11, pages 3305-3314.
Crossref
Crossref
D Wu, H E Zhau, W-C Huang, S Iqbal, F K Habib, O Sartor, L Cvitanovic, F F Marshall, Z Xu & L W K Chung. (2007) cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene 26:35, pages 5070-5077.
Crossref
Crossref
Rosa M. Martín-Orozco, Carmen Almaraz-Pro, F. Javier Rodríguez-Ubreva, M. Alicia Cortés, Santiago Ropero, Ramon Colomer, Pilar López-Ruiz & Begona Colás. (2007) EGF Prevents the Neuroendocrine Differentiation of LNCaP Cells Induced By Serum Deprivation: The Modulator Role of P13K/Akt. Neoplasia 9:8, pages 614-624.
Crossref
Crossref
Soo Ok Lee, Jae Yeon Chun, Nagalakshmi Nadiminty, Wei Lou & Allen C. Gao. (2007) Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. The Prostate 67:7, pages 764-773.
Crossref
Crossref
Konduru S.R. Sastry, Yelena Karpova, Sergey Prokopovich, Adrienne J. Smith, Brian Essau, Avynash Gersappe, Jonathan P. Carson, Michael J. Weber, Thomas C. Register, Yong Q. Chen, Raymond B. Penn & George Kulik. (2007) Epinephrine Protects Cancer Cells from Apoptosis via Activation of cAMP-dependent Protein Kinase and BAD Phosphorylation. Journal of Biological Chemistry 282:19, pages 14094-14100.
Crossref
Crossref
Paul D. Deeble, Michael E. Cox, Henry F. FriersonJr.Jr., Robert A. Sikes, Jodie B. Palmer, Robert J. Davidson, Eli V. Casarez, George P. Amorino & Sarah J. Parsons. (2007) Androgen-Independent Growth and Tumorigenesis of Prostate Cancer Cells Are Enhanced by the Presence of PKA-Differentiated Neuroendocrine Cells. Cancer Research 67:8, pages 3663-3672.
Crossref
Crossref
Nikita I. Ivanov, Simon P. Cowell, Paula Brown, Paul S. Rennie, Emma S. Guns & Michael E. Cox. (2007) Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clinical Nutrition 26:2, pages 252-263.
Crossref
Crossref
E C Nelson, A J Cambio, J C Yang, J-H Ok, P N LaraJrJr & C P Evans. (2006) Clinical implications of neuroendocrine differentiation in prostate cancer. Prostate Cancer and Prostatic Diseases 10:1, pages 6-14.
Crossref
Crossref
G P Amorino, P D Deeble & S J Parsons. (2006) Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway. Oncogene 26:5, pages 745-756.
Crossref
Crossref
Maria Vias, Glyn Burtt, Zoran Culig, Abhi Veerakumarasivam, David E. Neal & Ian G. Mills. (2007) A role for neurotensin in bicalutamide resistant prostate cancer cells. The Prostate 67:2, pages 190-202.
Crossref
Crossref
Ilaria Bellezza, Hannes Neuwirt, Constanze Nemes, Ilaria T. Cavarretta, Martin Puhr, Hannes Steiner, Alba Minelli, Georg Bartsch, Felix Offner, Alfred Hobisch, Wolfgang Doppler & Zoran Culig. (2006) Suppressor of Cytokine Signaling-3 Antagonizes cAMP Effects on Proliferation and Apoptosis and Is Expressed in Human Prostate Cancer. The American Journal of Pathology 169:6, pages 2199-2208.
Crossref
Crossref
Shalini Mitra, Lakshmanan Annamalai, Souvik Chakraborty, Kristen Johnson, Xiao-Hong Song, Surinder K. Batra & Parmender P. Mehta. (2006) Androgen-regulated Formation and Degradation of Gap Junctions in Androgen-responsive Human Prostate Cancer Cells. Molecular Biology of the Cell 17:12, pages 5400-5416.
Crossref
Crossref
Jacek Pinski, Qingcai Wang, Marcus L. Quek, Ariana Cole, Janine Cooc, Kathleen Danenberg & Peter V. Danenberg. (2006) Genistein-induced neuroendocrine differentiation of prostate cancer cells. The Prostate 66:11, pages 1136-1143.
Crossref
Crossref
Marcus L. Quek, Siamak Daneshmand, Sonali Rodrigo, Jie Cai, Tanya B. Dorff, Susan Groshen, Donald G. Skinner, Gary Lieskovsky & Jacek Pinski. (2006) Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer. Urology 67:6, pages 1247-1252.
Crossref
Crossref
G E Walker, R J Antoniono, H J Ross, T E Paisley & Y Oh. (2006) Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1. Oncogene 25:13, pages 1943-1954.
Crossref
Crossref
Christian G. Sauer, Alexandra Roemer & Rainer Grobholz. (2006) Genetic analysis of neuroendocrine tumor cells in prostatic carcinoma. The Prostate 66:3, pages 227-234.
Crossref
Crossref
Jeffrey D. Bub, Toshiaki Miyazaki & Yoshiki Iwamoto. (2006) Adiponectin as a growth inhibitor in prostate cancer cells. Biochemical and Biophysical Research Communications 340:4, pages 1158-1166.
Crossref
Crossref
Jinsheng Weng, Wenbin Ma, Dianne Mitchell, Jianshe Zhang & Mingyao Liu. (2005) Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors. Journal of Cellular Biochemistry 96:5, pages 1034-1048.
Crossref
Crossref
C. G. Sauer, L. Trojan & R. Grobholz. (2005) Bedeutung der neuroendokrinen Differenzierung im ProstatakarzinomRelevance of the neuroendocrine differentiation in prostatic carcinoma. Der Pathologe 26:6, pages 444-452.
Crossref
Crossref
Carolyn J.M. Best, John W. Gillespie, Yajun Yi, Gadisetti V.R. Chandramouli, Mark A. Perlmutter, Yvonne Gathright, Heidi S. Erickson, Lauren Georgevich, Michael A. Tangrea, Paul H. Duray, Sergio González, Alfredo Velasco, W. Marston Linehan, Robert J. Matusik, Douglas K. Price, William D. Figg, Michael R. Emmert-Buck & Rodrigo F. Chuaqui. (2005) Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy. Clinical Cancer Research 11:19, pages 6823-6834.
Crossref
Crossref
Gerold Untergasser, Eugen Plas, Gerald Pfister, Elmar Heinrich & Peter Berger. (2005) Interferon-γ induces neuroendocrine-like differentiation of human prostate basal-epithelial cells. The Prostate 64:4, pages 419-429.
Crossref
Crossref
DONGFENG TAN, XIUXIAN WU, MIN HOU, SOO O.K. LEE, WEI LOU, JIANMIN WANG, BAGIRATHAN JANARTHAN, SUJATHA NALLAPAREDDY, DONALD L. TRUMP & ALLEN C. GAO. (2005) INTERLEUKIN-6 POLYMORPHISM IS ASSOCIATED WITH MORE AGGRESSIVE PROSTATE CANCER. Journal of Urology 174:2, pages 753-756.
Crossref
Crossref
Thomas Tawadros, David Martin, Amar Abderrahmani, Hans-Jürg Leisinger, Gérard Waeber & Jacques-Antoine Haefliger. (2005) IB1/JIP-1 controls JNK activation and increased during prostatic LNCaP cells neuroendocrine differentiation. Cellular Signalling 17:8, pages 929-939.
Crossref
Crossref
Xuezhen Yang, Min-Wei Chen, Stephane Terry, Francis Vacherot, Dominique K. Chopin, Debra L. Bemis, Jan Kitajewski, Mitchell C. Benson, Yinglu Guo & Ralph Buttyan. (2005) A Human- and Male-Specific Protocadherin that Acts through the Wnt Signaling Pathway to Induce Neuroendocrine Transdifferentiation of Prostate Cancer Cells. Cancer Research 65:12, pages 5263-5271.
Crossref
Crossref
Lawrence S. Kirschner, Donna F. Kusewitt, Ludmila Matyakhina, William H. TownsIIII, J. Aidan Carney, Heiner Westphal & Constantine A. Stratakis. (2005) A Mouse Model for the Carney Complex Tumor Syndrome Develops Neoplasia in Cyclic AMP–Responsive Tissues. Cancer Research 65:11, pages 4506-4514.
Crossref
Crossref
Zoran Culig, Hannes Steiner, Georg Bartsch & Alfred Hobisch. (2005) Interleukin-6 regulation of prostate cancer cell growth. Journal of Cellular Biochemistry 95:3, pages 497-505.
Crossref
Crossref
KEVIN A. FIGUEIREDO, JODIE B. PALMER, ALICE L. MUI, COLLEEN C. NELSON & MICHAEL E. COX. (2005) Demonstration of Upregulated H2 Relaxin mRNA Expression during Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells and Production of Biologically Active Mammalian Recombinant 6 Histidine-Tagged H2 Relaxin. Annals of the New York Academy of Sciences 1041:1, pages 320-327.
Crossref
Crossref
Gavin P. Dunn, Kathleen C.F. Sheehan, Lloyd J. Old & Robert D. Schreiber. (2005)
IFN Unresponsiveness in LNCaP Cells Due to the Lack of
JAK1
Gene Expression
. Cancer Research 65:8, pages 3447-3453.
Crossref
Crossref
Rosa M. Sainz, Juan C. Mayo, Dun-xian Tan, Josefa León, Lucien Manchester & Russel J. Reiter. (2005) Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. The Prostate 63:1, pages 29-43.
Crossref
Crossref
Daniel J. George, Susan Halabi, Timothy F. Shepard, Ben Sanford, Nicholas J. Vogelzang, Eric J. Small & Philip W. Kantoff. (2005) The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480. Clinical Cancer Research 11:5, pages 1815-1820.
Crossref
Crossref
Jodie Palmer, Matthias Ernst, Annet Hammacher & Paul J. Hertzog. (2005) Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo. The Prostate 62:3, pages 282-289.
Crossref
Crossref
Nadezda Vashchenko & Per-Anders Abrahamsson. (2005) Neuroendocrine Differentiation in Prostate Cancer: Implications for New Treatment Modalities. European Urology 47:2, pages 147-155.
Crossref
Crossref
Qingcai Wang, Dimitris Horiatis & Jacek Pinski. (2004) Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation. International Journal of Cancer 111:4, pages 508-513.
Crossref
Crossref
Netta Sion-Vardy, Alina Tzikinovsky, Arkady Bolotyn, Shraga Segal & Daniel Fishman. (2004) Augmented expression of chromogranin A and serotonin in peri-malignant benign prostate epithelium as compared to adenocarcinoma. Pathology - Research and Practice 200:7-8, pages 493-499.
Crossref
Crossref
Soo Ok Lee, Wei Lou, Candace S. Johnson, Donald L. Trump & Allen C. Gao. (2004) Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. The Prostate 60:3, pages 178-186.
Crossref
Crossref
Eva H. Nunlist, Igor Dozmorov, Yuhong Tang, Rick Cowan, Michael Centola & Hsueh-Kung Lin. (2004) Partitioning of 5α-dihydrotestosterone and 5α-androstane-3α, 17β-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation. The Journal of Steroid Biochemistry and Molecular Biology 91:3, pages 157-170.
Crossref
Crossref
Dimitris Horiatis, Qingcai Wang & Jacek Pinski. (2004) A new screening system for proliferation-independent anti-cancer agents. Cancer Letters 210:1, pages 119-124.
Crossref
Crossref
Shaozhen Xie, Hui-Kuan Lin, Jing Ni, Lin Yang, Liang Wang, P. Anthony di Sant'Agnese & Chawnshang Chang. (2004) Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells. The Prostate 60:1, pages 61-67.
Crossref
Crossref
V Michalaki, K Syrigos, P Charles & J Waxman. (2004) Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer. British Journal of Cancer 90:12, pages 2312-2316.
Crossref
Crossref
C A Rothermund, V K Gopalakrishnan & J K Vishwanatha. (2004) Androgen signaling and post-transcriptional downregulation of Bcl-2 in androgen-unresponsive prostate cancer. Prostate Cancer and Prostatic Diseases 7:2, pages 158-164.
Crossref
Crossref
K Vanoverberghe, F Vanden Abeele, P Mariot, G Lepage, M Roudbaraki, J L Bonnal, B Mauroy, Y Shuba, R Skryma & N Prevarskaya. (2003) Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death & Differentiation 11:3, pages 321-330.
Crossref
Crossref
Andreas I. Evangelou, Scott F. Winter, Wendy J. Huss, Robert A. Bok & Norman M. Greenberg. (2004) Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype. Journal of Cellular Biochemistry 91:4, pages 671-683.
Crossref
Crossref
Jayoung Kim, Rosalyn M. Adam, Keith R. Solomon & Michael R. Freeman. (2004) Involvement of Cholesterol-Rich Lipid Rafts in Interleukin-6-Induced Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells. Endocrinology 145:2, pages 613-619.
Crossref
Crossref
Yehia Daaka. (2004) G Proteins in Cancer: The Prostate Cancer Paradigm. Science's STKE 2004:216.
Crossref
Crossref
Beatrice S. Knudsen & Magnus Edlund. 2004.
31
67
.
Jonathan R. Brody, Shrihari S. Kadkol, M. Claire Hauer, Fatemeh Rajaii, Jessica Lee & Gary R. Pasternack. (2004) pp32 Reduction Induces Differentiation of TSU-Pr1 Cells. The American Journal of Pathology 164:1, pages 273-283.
Crossref
Crossref
Michael R. Freeman & Keith R. Solomon. (2004) Cholesterol and prostate cancer. Journal of Cellular Biochemistry 91:1, pages 54-69.
Crossref
Crossref
Xiu-Qing Zhang, Dmitry Kondrikov, Ta-Chun Yuan, Fen-Fen Lin, Joel Hansen & Ming-Fong Lin. (2003) Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells. Oncogene 22:43, pages 6704-6716.
Crossref
Crossref
Jae-Il Park, Min-Goo Lee, Kyucheol Cho, Bum-Joon Park, Kwon-Seok Chae, Do-Sun Byun, Byung-Kyu Ryu, Yong-Keun Park & Sung-Gil Chi. (2003) Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathways. Oncogene 22:28, pages 4314-4332.
Crossref
Crossref
George S. Laszlo & Neil M. Nathanson. (2003) Src Family Kinase-independent Signal Transduction and Gene Induction by Leukemia Inhibitory Factor. Journal of Biological Chemistry 278:30, pages 27750-27757.
Crossref
Crossref
Yue Xu, Sunita Iyengar, Richard L. Roberts, Scott B. Shappell & Donna M. Peehl. (2003) Primary culture model of peroxisome proliferator-activated receptor ? activity in prostate cancer cells. Journal of Cellular Physiology 196:1, pages 131-143.
Crossref
Crossref
Hannes Steiner, Sonia Godoy-Tundidor, Hermann Rogatsch, Andreas P. Berger, Dietmar Fuchs, Barbara Comuzzi, Georg Bartsch, Alfred Hobisch & Zoran Culig. (2003) Accelerated in Vivo Growth of Prostate Tumors that Up-Regulate Interleukin-6 Is Associated with Reduced Retinoblastoma Protein Expression and Activation of the Mitogen-Activated Protein Kinase Pathway. The American Journal of Pathology 162:2, pages 655-663.
Crossref
Crossref
Joseph Lotem & Leo Sachs. (2002) Epigenetics wins over genetics: induction of differentiation in tumor cells. Seminars in Cancer Biology 12:5, pages 339-346.
Crossref
Crossref
Philip J.S Stork & John M Schmitt. (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends in Cell Biology 12:6, pages 258-266.
Crossref
Crossref